Holen Sie sich die Stockscreener-App
492.36
0.19%
1.0243
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt VRTX?
Forum
Prognose
Aktiensplit
Vertex Pharmaceuticals Inc Aktie (VRTX) Neueste Nachrichten
Vertex Pharma enters Russell 1000 value, shares reflect mixed benchmark shift - AD HOC NEWS
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) added to Russell 1000 Value Benchmark - marketscreener.com
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 1000 Growth Benchmark - marketscreener.com
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com
Vertex Pharma analyst optimism builds ahead earnings week, shares trade near recent high - Ad-hoc-news.de
Price to book forward of Vertex Pharmaceuticals Incorporated – NASDAQ:VRTX - TradingView
Price to earnings forward of Vertex Pharmaceuticals Incorporated – NASDAQ:VRTX - TradingView
Vertex Pharma strategy in cystic fibrosis, shares anchored in the NASDAQ-100 healthcare field - Ad-hoc-news.de
CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
Form 144 VERTEX PHARMACEUTICALS INC / MA For: 26 June - Investing.com UK
Form 144 VERTEX PHARMACEUTICALS INC / MA For: 26 June By Investing.com - Investing.com South Africa
Enterprise value to EBIT forward of Vertex Pharmaceuticals Incorporated – NASDAQ:VRTX - TradingView
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today - Yahoo Finance
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Price to sales forward of Vertex Pharmaceuticals Incorporated – NASDAQ:VRTX - TradingView
VRTX (NASDAQ) affiliate files Form 144: 596 shares vest, multiple sales by Carmen R. Bozic - Stock Titan
Enterprise value to revenue forward of Vertex Pharmaceuticals Incorporated – NASDAQ:VRTX - TradingView
Vertex Pharmaceuticals Incorporated Actuals & Estimates (NASDAQ:VRTX) - TradingView
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript - Fortune
Vertex Pharma leads biotech this week, shares hover near record highs - Ad-hoc-news.de
Fierce Biotech Layoff Tracker 2026: BioCryst ends internal programs; Biogen sheds Apellis R&D roles - Fierce Biotech
Vertex Pharmaceuticals Incorporated Actuals & Estimates (BMV:VRTX) - TradingView
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Why Vertex Pharmaceuticals (NASDAQ:VRTX) Is Drawing Fresh Attention? - Kalkine Media
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade) (VRTX) - Seeking Alpha
Is Vertex Pharmaceuticals Successfully Diversifying Beyond Cystic Fibrosis - Kavout | AI
Former Vertex, GSK exec launches science-first pet nutrition company - The Business Journals
Vertex Pharmaceuticals Inc (VRTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
A Loophole Brings Cystic Fibrosis Patients a ‘Miracle Drug’ in Generic Form - The New York Times
Vertex (VRTX) EVP and CMO Carmen Bozic sells 1,020 shares under 10b5-1 plan - Stock Titan
Vertex Pharma with clear analyst backing, shares supported by strong consensus estimates - Ad-hoc-news.de
Vertex Pharmaceuticals (VRTX) Stock After Strong Multi‑Year Run Is The Price Still Reasonable - Yahoo Finance
Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX) - Yahoo Finance
Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda - GlobeNewswire Inc.
Vertex Pharmaceuticals (NASDAQ:VRTX): A GARP Growth Stock with Reasonable Valuation and Strong Fundamentals - ChartMill
Vertex Pharmaceuticals Inc (VRTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vertex Pharmaceuticals Inc (VRTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 3.45% on Jun 22: What Signal Does It Send? - TradingKey
2 Reasons to Like VRTX (and 1 Not So Much) - Yahoo Finance
Barclays Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $615 - Moomoo
How Strong Pediatric CASGEVY Data Could Impact Vertex Pharmaceuticals’ (VRTX) Gene Therapy Investment Narrative - simplywall.st
Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up. Here's What That Means for Both Stocks. - The Motley Fool
Vertex Pharma Stockweekly review in a strong biotech sector - Ad-hoc-news.de
Can Vertex's Kidney Pipeline Power Its Next Growth Phase? - TradingView
Nia Impact Solutions Fund's Vertex Pharmaceuticals Inc(VRTX) Holding History - GuruFocus
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock - Yahoo Finance
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Vertex Pharmaceuticals CFO’s case for thinking like a portfolio manager - CFO.com
Citi Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $585 - Moomoo
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):